[1]
Ayón, C., Castán, D., Mora, A., Naranjo, D., Obando, F. and Mora, J.J. 2022. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment. Borneo Journal of Pharmacy. 5, 3 (Aug. 2022), 229–246. DOI:https://doi.org/10.33084/bjop.v5i3.2095.